Most Read Articles
2 days ago
Exposure to corticosteroids in patients with autoimmune hepatitis (AIH) appears to contribute to increased risks of cataract, diabetes and bone fractures, a study has found. Notably, the fracture risk is elevated at low doses, while the risk of adverse events overall is dose-dependent and is reversible.
Stephen Padilla, Yesterday
Intensive urate lowering with the combination therapy of verinurad plus febuxostat is successful in lowering the urinary albumin to creatinine ratio (UACR) in patients with type 2 diabetes mellitus (T2DM), albuminuria and hyperuricaemia, according to a study presented at the American Society of Nephrology (ASN) Kidney Week 2019.
3 days ago
Monotherapy with tocilizumab (TCZ) shows good tolerability profile and results in remission in most patients with polymyalgia rheumatica (PMR) despite the absence of glucocorticoids, according to the 2-year results of a single-centre, open‐label pilot study.
Roshini Claire Anthony, 6 days ago

Patients with type 2 diabetes (T2D) and severe obesity may have a greater chance of complete T2D remission 1 year after gastric bypass rather than sleeve gastrectomy, according to results of the Oseberg* trial.

Product Highlight - Bisolvon

29 Mar 2019
  • Active Ingredient: Bromhexine hydrochloride 8 mg/5 mL (high strength).
  • Indications: Secretolytic therapy in acute and chronic bronchopulmonary diseases associated with abnormal mucus secretion and impaired mucus transport.
  • Dosage & Administration: Adults and children over 12 years: 5 mL (1 tsp) 3 times daily. Children 6-12 years: 2.5 mL (1/2 tsp) 3 times daily.
  • General: At commencement of treatment, it may be necessary to increase the total daily dose up to 48 mg in adults.
    The syrup is sugar-free and alcohol-free therefore suitable for diabetics and small children.
    Patients being treated with Bisolvon should be notified of an expected increase in the flow of secretions.
    In acute respiratory indications, medical device should be sought if symptoms do not improve or worsen during course of therapy.
  • Presentation: Syrup(Choco-Cherry) 8 mg/5 mL x 60 mL x 1’s.

Related MIMS Drugs

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Thailand digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
2 days ago
Exposure to corticosteroids in patients with autoimmune hepatitis (AIH) appears to contribute to increased risks of cataract, diabetes and bone fractures, a study has found. Notably, the fracture risk is elevated at low doses, while the risk of adverse events overall is dose-dependent and is reversible.
Stephen Padilla, Yesterday
Intensive urate lowering with the combination therapy of verinurad plus febuxostat is successful in lowering the urinary albumin to creatinine ratio (UACR) in patients with type 2 diabetes mellitus (T2DM), albuminuria and hyperuricaemia, according to a study presented at the American Society of Nephrology (ASN) Kidney Week 2019.
3 days ago
Monotherapy with tocilizumab (TCZ) shows good tolerability profile and results in remission in most patients with polymyalgia rheumatica (PMR) despite the absence of glucocorticoids, according to the 2-year results of a single-centre, open‐label pilot study.
Roshini Claire Anthony, 6 days ago

Patients with type 2 diabetes (T2D) and severe obesity may have a greater chance of complete T2D remission 1 year after gastric bypass rather than sleeve gastrectomy, according to results of the Oseberg* trial.